541 related articles for article (PubMed ID: 2215562)
1. Eosinophilic inflammation in asthma.
Bousquet J; Chanez P; Lacoste JY; Barnéon G; Ghavanian N; Enander I; Venge P; Ahlstedt S; Simony-Lafontaine J; Godard P
N Engl J Med; 1990 Oct; 323(15):1033-9. PubMed ID: 2215562
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons.
Hussain M; Liu G
Cells; 2024 Feb; 13(5):. PubMed ID: 38474348
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways underlying lung-brain axis signaling in asthma: Relevance for psychopathology and neuroinflammation.
Dill-McFarland KA; Altman MC; Esnault S; Jarjour NN; Busse WW; Rosenkranz MA
J Allergy Clin Immunol; 2024 Jan; 153(1):111-121. PubMed ID: 37730134
[TBL] [Abstract][Full Text] [Related]
4. [Research progress on eosinophils in lung cancer].
Wei YQ; Lyu LH; Li M
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1895-1900. PubMed ID: 38008583
[TBL] [Abstract][Full Text] [Related]
5. Blood eosinophils and lung function loss: from passive prediction to active prevention?
Ramakrishnan S; Montgomery B; Pavord ID
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38816039
[No Abstract] [Full Text] [Related]
6. The eosinophil paradox in type 2 high severe eosinophilic unified airways disease.
Lipworth B; Stewart K; RuiWen Kuo C; Chan R
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):265. PubMed ID: 38185497
[No Abstract] [Full Text] [Related]
7. Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG; Liu MC; Pavord ID; Brusselle GG; FitzGerald JM; Chetta A; Humbert M; Katz LE; Keene ON; Yancey SW; Chanez P;
N Engl J Med; 2014 Sep; 371(13):1198-207. PubMed ID: 25199059
[TBL] [Abstract][Full Text] [Related]
8. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Pavord ID; Korn S; Howarth P; Bleecker ER; Buhl R; Keene ON; Ortega H; Chanez P
Lancet; 2012 Aug; 380(9842):651-9. PubMed ID: 22901886
[TBL] [Abstract][Full Text] [Related]
9. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
Chung KF; Wenzel SE; Brozek JL; Bush A; Castro M; Sterk PJ; Adcock IM; Bateman ED; Bel EH; Bleecker ER; Boulet LP; Brightling C; Chanez P; Dahlen SE; Djukanovic R; Frey U; Gaga M; Gibson P; Hamid Q; Jajour NN; Mauad T; Sorkness RL; Teague WG
Eur Respir J; 2014 Feb; 43(2):343-73. PubMed ID: 24337046
[TBL] [Abstract][Full Text] [Related]
10. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
[TBL] [Abstract][Full Text] [Related]
11. Asthma phenotypes: the evolution from clinical to molecular approaches.
Wenzel SE
Nat Med; 2012 May; 18(5):716-25. PubMed ID: 22561835
[TBL] [Abstract][Full Text] [Related]
12. Anti-interleukin-5 therapy in severe asthma.
Garcia G; Taillé C; Laveneziana P; Bourdin A; Chanez P; Humbert M
Eur Respir Rev; 2013 Sep; 22(129):251-7. PubMed ID: 23997052
[TBL] [Abstract][Full Text] [Related]
13. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.
Schleich FN; Manise M; Sele J; Henket M; Seidel L; Louis R
BMC Pulm Med; 2013 Feb; 13():11. PubMed ID: 23442497
[TBL] [Abstract][Full Text] [Related]
14. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Bel EH; Wenzel SE; Thompson PJ; Prazma CM; Keene ON; Yancey SW; Ortega HG; Pavord ID;
N Engl J Med; 2014 Sep; 371(13):1189-97. PubMed ID: 25199060
[TBL] [Abstract][Full Text] [Related]
15. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
[TBL] [Abstract][Full Text] [Related]
16. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ
Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
[TBL] [Abstract][Full Text] [Related]
17. Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".
Spector SL; Tan RA
J Asthma; 2012 Oct; 49(8):807-10. PubMed ID: 22900679
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL5 therapy for asthma and beyond.
Mukherjee M; Sehmi R; Nair P
World Allergy Organ J; 2014; 7(1):32. PubMed ID: 25709744
[TBL] [Abstract][Full Text] [Related]
19. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
[TBL] [Abstract][Full Text] [Related]
20. HEDD: the human epigenetic drug database.
Qi Y; Wang D; Wang D; Jin T; Yang L; Wu H; Li Y; Zhao J; Du F; Song M; Wang R
Database (Oxford); 2016; 2016():. PubMed ID: 28025347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
